Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. ACN
3. IBM
4. MU
5. DPZ
6. NVDA
7. PRIM
8. META
9. SPY
10. SPCX

Go back to Ultragenyx Reports Fourth Quarter 2015 and Full-Year 2015 Financial Results and Corporate Update

Ultragenyx Pharma (RARE) Misses Q4 EPS by 28c

February 25, 2016 4:27 PM EST

Ultragenyx Pharma (NASDAQ: RARE) reported Q4 EPS of ($1.42), $0.28 worse than the analyst estimate of ($1.14).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.

... More